For nearly a decade, Dan Buettner has researched the places people live longest, healthiest and happiest.
The federal sequester created a 2 percent across-the-board cut to Medicare, the national health insurance program for Americans age 65 and older.
Among those affected by the cuts are elderly cancer patients who, for a number of reasons including convenience and cost, rely on community cancer clinics instead of hospitals to get their chemotherapy treatment.
“It’s more expensive for Medicare, more expensive for the patient and it’s not local to where they live.”
Some clinics are now unable to cover the cost of cancer drugs since the government reduced its drug reimbursements as part of the sequester cuts. In some cases, the clinics are turning away Medicare patients, forcing them to go to hospitals.
One of those clinics is North Shore Hematology Oncology Associates in New York, which has decided to turn away one-third of its 16,000 Medicare patients in order to make ends meet.
The clinic’s chief executive, Dr. Jeff Vacirca, says ironically, shifting patients’ care from a clinic to a hospital costs Medicare $7,000 more per year per patient.
“It’s more expensive for Medicare, more expensive for the patient and it’s not local to where they live,” Vacirca told Here & Now’s Robin Young.
And hospitals aren’t happy about it either.
“A lot of the community hospitals are faced with the same sequester cuts we are, and are not interested in getting a high influx of patients,” Vacirca said.
Many elderly cancer patients prefer clinics to hospitals. They’re less expensive, closer to home and doesn’t take a whole day to be treated.
Judy Weiner, 73, has been treated for breast cancer by Dr. Vacirca for the past four years. Her husband has also been treated for metastatic colon cancer for two and a half years.
“The fears that my husband and I have associated with moving over to a hospital for chemo treatment are those associated with infection — there’s a high rate of infection at hospitals,” Weiner told Here & Now. “From a patient perspective, I’m not leaving.”
There is a bill in Congress that would exempt chemotherapy drugs from the 2 percent cut.
“We’re hoping that Congress is going to come to their senses,” said Dr. Vacirca. “You know, we saw them fix the FAA so that we didn’t have to deal with late flights. I find it somewhat ironic that late flights are more important than our nation’s cancer care.”